Companies / Vera Therapeutics, Inc.
Vera Therapeutics, Inc.
Nasdaq: VERACIK 1831828BRISBANE, CA
Financials
Ownership
72.1M shares outstanding · as of Jul 29, 2026
Ownership
| Insiders | 0.97% | 695,706 |
| 10%+ / strategic | 22.78% | 16,417,989 |
| Institutions | 87.60% | 63,124,512 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 13
View all →| Insider | % of shares | Shares |
|---|---|---|
Fordyce MarshallCEOPRESIDENT AND CEO · Director | 0.36% | 257,163 |
Grant SeanCHIEF FINANCIAL OFFICER | 0.16% | 114,181 |
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR | 0.11% | 75,754 |
Skelton Laurence MatthewChief Commercial Officer | 0.09% | 64,218 |
Brenner RobertChief Medical Officer | 0.07% | 50,947 |
Johnson David LeeChief Operating Officer | 0.06% | 45,727 |
Turner William D.Chief Regulatory Officer | 0.06% | 45,313 |
Wright-Mitchell JaneChief Legal Officer | 0.06% | 42,403 |
Enright Patrick GDirector | — | — |
Hite ChristopherDirector | — | — |
Institutional holders 228
View all →| Holder | Value | % of shares |
|---|---|---|
| $298.21M | 8.17% | |
| $246.64M | 7.98% | |
| $180.81M | 4.95% | |
| $178.02M | 5.76% | |
| $173.85M | 4.76% | |
| $155.58M | 4.26% | |
| $149.74M | 5.17% | |
| $146.14M | 4.00% | |
| $142.86M | 3.91% | |
| $141.49M | 3.88% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $63.17M | +1.5M +55.00% | 4,148,786 5.76% of shares | high |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $39.57M | +922K +19.11% | 5,747,760 7.98% of shares | medium |
| Q2 2026 as of | Deutsche Bank AG 13F manager | Add | — | $32.38M | +755K +217.22% | 1,102,106 1.53% of shares | medium |
| Q1 2026 as of | Schroder Investment Management Group 13F manager | Add | — | $17.24M | +453K +1424.22% | 484,381 0.67% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | Add | — | $14.69M | +365K +672.30% | 419,570 0.58% of shares | medium |
| Q1 2026 as of | Deerfield Management Company, L.P. 13F manager | Trim | — | $-13.58M | -338K -8.32% | 3,722,100 5.17% of shares | medium |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | — | $10.62M | +264K +136.45% | 457,300 0.63% of shares | medium |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | — | $10.32M | +204K +41.56% | 694,319 0.96% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| State Street Corporation | Passive13G | — |
| Vanguard Group Inc | Passive13G/A | — |
| Vanguard Group Inc | Passive13G | — |
| Fmr LLC | Passive13G/A | — |
| T. Rowe Price Associates, Inc. | Passive13G/A | — |
| Deep Track Capital, LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VERA | — | 92337R101 |